Expertise in Human and Animal health solid form characterization and formulation development. We deliver both experimental support and consulting services to biotechnology and pharmaceutical companies, not-for-profit organizations and complementary CROs. We are member of the association AFSSI, 1st French research center in Life Sciences, as a founding member and member of the board of Directors. Since March 2019 Joel Vacus, Drugabilis CEO & CSO, is vice-President of AFSSI. https://www.afssi.fr/ Feel free to contact us in order to exchange about your preclinical drug development! contact@drugabilis.com
Looking for a particular Drugabilis employee's phone or email?
The Drugabilis annual revenue was $4 million in 2026.
Joel Vacus is the CEO and CSO of Drugabilis.
7 people are employed at Drugabilis.
Drugabilis is based in Villejust, Île-de-France.
The NAICS codes for Drugabilis are [5419, 541, 54, 54192, 541921].
The SIC codes for Drugabilis are [722, 72].